Maxigen Biotech Inc. · TWSE:1783

Maxigen Biotech Inc. financial statements

Maxigen Biotech Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue811.6M680.7M622.1M604.4M512.0M457.7M452.2M427.7M427.6M336.4M
Cost of revenue247.8M197.3M198.0M230.4M250.9M243.2M234.9M245.1M267.3M201.5M
Gross profit563.7M483.3M424.1M374.0M261.0M214.5M217.3M182.6M160.3M134.9M
Research and development126.1M111.8M68.6M99.6M75.7M69.2M66.9M50.7M43.3M36.3M
Selling, general and administrative183.9M82.2M72.6M63.0M52.8M50.2M44.6M44.9M46.9M60.4M
Operating income261.0M194.4M149.8M170.6M100.7M76.9M76.1M46.1M21.0M-11.3M
Depreciation and amortization32.1M27.0M27.6M29.6M32.9M33.2M32.5M26.2M25.8M18.1M
EBITDA293.2M221.4M177.5M200.1M133.6M110.1M108.6M72.4M46.8M6.80M
Interest expense43.0K0068.0K196.0K250.0K3.43M4.02M4.12M4.81M
Income before tax304.9M225.5M193.1M165.8M97.5M76.7M72.8M57.3M16.7M-12.0M
Income tax39.6M35.4M27.3M26.4M9.80M13.4M12.7M253.0K908.0K288.0K
Net income265.3M190.2M165.8M139.4M87.7M63.3M60.1M57.1M15.8M-12.2M
Earnings per share, basic2.962.121.851.561.040.790.680.670.21-0.16

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents576.2M639.1M431.1M790.9M513.3M209.8M267.6M184.8M182.2M96.6M
Short-term investments301.5M1.50M1.50M10.3M26.9M13.1M165.0M232.3M123.0M258.1M
Receivables132.2M103.9M97.1M100.1M114.4M100.3M97.8M86.5M126.1M110.3M
Inventory99.2M75.7M85.2M75.3M79.0M87.0M88.1M82.6M94.0M91.0M
Current assets1.12B830.3M619.6M993.2M783.6M432.1M640.2M599.5M585.1M574.0M
Property, plant and equipment434.6M465.5M481.5M502.1M494.0M502.0M503.2M
Goodwill1
Total assets1.89B1.58B1.49B1.45B1.27B956.5M1.19B1.14B1.10B1.10B
Accounts payable86.8M50.0M17.1M35.9M40.1M33.0M34.0M31.0M40.5M33.8M
Current liabilities349.1M205.9M131.4M151.5M116.1M86.6M321.9M292.4M83.0M87.7M
Long-term debt013.2M14.9M
Total debt101.4M50.0K9.74M12.1M14.7M213.2M14.9M16.5M
Total liabilities355.5M207.4M131.9M152.1M123.5M96.2M334.2M292.5M307.7M316.0M
Shareholders' equity1.54B1.38B1.36B1.30B1.14B860.2M851.3M843.0M796.3M781.4M
Shares outstanding89.6M89.7M89.5M89.4M84.1M80.6M87.8M85.3M76.5M76.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations290.2M298.2M171.2M268.3M117.6M74.4M94.4M170.6M41.2M34.7M
Capital spending-82.6M-31.8M-22.4M-14.4M-15.4M-11.3M-23.7M-20.2M-29.0M-72.7M
Free cash flow207.6M266.5M148.8M253.9M102.1M63.1M70.7M150.4M12.2M-38.0M
Cash from investing-383.0M-29.1M-490.2M10.4M-2.77M139.1M42.6M-142.3M50.3M-141.8M
Cash from financing30.7M-59.7M-41.4M-1.05M188.7M-271.4M-54.4M-25.7M-5.28M-86.0M
Dividends paid-74.4M-89.0M-42.4M-56.3M-54.2M-51.9M-10.8M-10.8M-10.8M
Share buybacks-100.0K0-33.1M
Change in cash-62.9M208.0M-359.9M277.6M303.5M-57.9M82.8M2.63M85.6M-196.0M